Terumo BCT Europe N.V. is a global leader in the design and manufacture of medical devices and single-use disposables for blood component and cellular technologies, and has been supplying systems to the blood industry for over thirty years. Terumo BCT’s Quantum Cell Expansion System is a functionally closed CE marked Class IIb medical device designed to bring reproducibility and scalability to the production of ATMPs. By minimizing the need for hands-on interventions, and increasing reproducibility, the Quantum system is helping companies automate cell culture. The Quantum system has been used worldwide at biotechnology companies, research hospitals, and academic centers for the ex vivo expansion of clinical-scale quantities of mesenchymal stem cells (MSCs).
Terumo BCT will act as an advisor on the NEPHSTROM programme to supply, implement and validate a controlled, robust, and reproducible manufacturing process for the expansion of cord blood derived STRO1 stem cells to clinical-scale quantities of a cellular product for human infusion.